Assertio Holdings (ASRT) Long-Term Debt Repayments (2020 - 2023)

Assertio Holdings' (ASRT) quarterly Long-Term Debt Repayments came in at $10.5 million in Q1 2023, up 50.0% quarter-over-quarter from $7.0 million in Q4 2020.

Assertio Holdings (ASRT) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends

Assertio Holdings has disclosed Long-Term Debt Repayments across 2 years of filings, most recently posting $10.5 million for Q1 2023.

  • Long-Term Debt Repayments for Q1 2023 came in at $10.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $10.5 million (up 50.0% YoY), and the FY2023 annual result was $10.5 million, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at $10.5 million for Q1 2023 at Assertio Holdings, up from $7.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $10.5 million in Q1 2023 to a low of -$7.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 23.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 216,000.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Assertio Holdings 150.78 Mn 79.21 Mn 7.22 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 10.50 Mn
Mar 31, 2023 10.50 Mn
Dec 31, 2020 7.00 Mn
Dec 31, 2020 7.00 Mn
Sep 30, 2020 -7.00 Mn
Sep 30, 2020 -7.00 Mn